Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment:an Open-label, Randomized, Controlled Phase II Clinical Study [Phase 2]

View source ↗

Summary

This clinical trial update outlines an open-label Phase II randomized study. It compares a second-line regimen combined with radiotherapy versus without radioth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Intrahepatic Cholangiocarcinoma (Icc) | Phase 2 | Status: NOT_YET_RECRUITING